Chronic hyperprolactinemia and changes in dopamine neurons

被引:23
|
作者
Mohankumar, PS
Mohankumar, SMJ
Kaleem, S
Quadri, SK
Voogt, JL
机构
[1] UNIV KANSAS,MED CTR,DEPT PHYSIOL,KANSAS CITY,KS 66160
[2] KANSAS STATE UNIV,DEPT ANAT & PHYSIOL,MANHATTAN,KS 66506
关键词
prolactin; catecholamines; aging; microdissection; HPLC-EC;
D O I
10.1016/S0361-9230(96)00369-3
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The tuberoinfundibular dopaminergic (TIDA) system is known to inhibit prolactin (PRL) secretion. In young animals this system responds to acute elevations in serum PRL by increasing its activity. However, this responsiveness is lost in aging rats with chronically high serum PRL levels. The purpose of this study was to induce hyperprolactinemia in rats for extended periods of time and examine its effects on dopaminergic systems in the brain. Hyperprolactinemia was induced by treatment with haloperidol, a dopamine receptor antagonist, and Palkovits' microdissection technique in combination with high-performance liquid chromatography was used to measure neurotransmitter concentrations in several areas of the brain. After 6 months of hyperprolactinemia, dopamine (DA) concentrations in the median eminence (ME) increased by 84% over the control group. Nine months of hyperprolactinemia produced a 50% increase in DA concentrations in the ME over the control group. However, DA response was lost if a 9-month long haloperidol-induced hyperprolactinemia was followed by a 1 1/2, month-long extremely high increase in serum PRL levels produced by implantation of MMQ cells under the kidney capsule. There was no change in the levels of DA, norepinephrine (NE), serotonin (5-HT), or their metabolites in the arcuate nucleus (AN), medial preoptic area (MPA), caudate putamen (CP), substantia nigra (SN), and zona incerta (ZI), except for a decrease in 5-hydroxyindoleacetic acid (5-HIAA) in the AN after B-months of hyperprolactinemia and an increase in DA concentrations in the AN after g-months of hyperprolactinemia. These results demonstrate that hyperprolactinemia specifically affects TIDA neurons and these effects vary, depending on the duration and intensity of hyperprolactinemia. The age-related decrease in hypothalamic dopamine function may be associated with increases in PRL secretion. (C) 1997 Elsevier Science Inc.
引用
收藏
页码:435 / 441
页数:7
相关论文
共 50 条
  • [41] Dopamine transporter-immunoreactive neurons decrease with age in the human substantia nigra
    Ma, SY
    Ciliax, BJ
    Stebbins, G
    Jaffar, S
    Joyce, JN
    Cochran, EJ
    Kordower, JH
    Mash, DC
    Levey, AI
    Mufson, EJ
    JOURNAL OF COMPARATIVE NEUROLOGY, 1999, 409 (01) : 25 - 37
  • [42] Neuromedin U suppresses prolactin secretion via dopamine neurons of the arcuate nucleus
    Nakahara, Keiko
    Maruyama, Keisuke
    Ensho, Takuya
    Mori, Kenji
    Miyazato, Mikiya
    Kangawa, Kenji
    Uemura, Ryoko
    Sakoda, Hideyuki
    Nakazato, Masamitsu
    Murakami, Noboru
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2020, 521 (02) : 521 - 526
  • [43] Suppressive effects of chronic hyperprolactinemia on penile erection and yawning following administration of apomorphine to pituitary-transplanted rats
    Sato, F
    Aoki, H
    Nakamura, K
    Taguchi, M
    Aoki, T
    Yasuda, N
    JOURNAL OF ANDROLOGY, 1997, 18 (01): : 21 - 25
  • [44] GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR GENE THERAPY AMELIORATES CHRONIC HYPERPROLACTINEMIA IN SENILE RATS
    Morel, G. R.
    Sosa, Y. E.
    Bellini, M. J.
    Carri, N. G.
    Rodriguez, S. S.
    Bohn, M. C.
    Goya, R. G.
    NEUROSCIENCE, 2010, 167 (03) : 946 - 953
  • [45] LIFELONG ETHANOL-CONSUMPTION ENHANCES THE AGE-RELATED-CHANGES IN RAT SYMPATHETIC NEURONS
    JAATINEN, P
    KIIANMAA, K
    HERVONEN, A
    MECHANISMS OF AGEING AND DEVELOPMENT, 1992, 63 (02) : 193 - 205
  • [46] Maternal dopamine agonist treatment before pregnancy reverses infertility and hyperprolactinemia in hCG-overexpressing mice through lactation: Evidence of generational effects
    Ratner, Laura D.
    Lopez, Agustina Marcial
    Giorgio, Noelia P. Di
    Poutanen, Matti
    Huhtaniemi, Ilpo
    Rulli, Susana B.
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2025, 602
  • [47] Treating symptomatic hyperprolactinemia in women with schizophrenia: presentation of the ongoing DAAMSEL clinical trial (Dopamine partial Agonist, Aripiprazole, for the Management of Symptomatic ELevated prolactin)
    Deanna L Kelly
    Heidi J Wehring
    Amber K Earl
    Kelli M Sullivan
    Faith B Dickerson
    Stephanie Feldman
    Robert P McMahon
    Robert W Buchanan
    Dale Warfel
    William R Keller
    Bernard A Fischer
    Joo-Cheol Shim
    BMC Psychiatry, 13
  • [48] Effects of chronic ethanol consumption and aging on dopamine, serotonin, and metabolites
    Woods, JM
    Druse, MJ
    JOURNAL OF NEUROCHEMISTRY, 1996, 66 (05) : 2168 - 2178
  • [49] Treating symptomatic hyperprolactinemia in women with schizophrenia: presentation of the ongoing DAAMSEL clinical trial (Dopamine partial Agonist, Aripiprazole, for the Management of Symptomatic ELevated prolactin)
    Kelly, Deanna L.
    Wehring, Heidi J.
    Earl, Amber K.
    Sullivan, Kelli M.
    Dickerson, Faith B.
    Feldman, Stephanie
    McMahon, Robert P.
    Buchanan, Robert W.
    Warfel, Dale
    Keller, William R.
    Fischer, Bernard A.
    Shim, Joo-Cheol
    BMC PSYCHIATRY, 2013, 13
  • [50] ULTRASTRUCTURAL-CHANGES IN RAT MAMMOTROPES FOLLOWING INCUBATION WITH DOPAMINE
    JONEJA, M
    REIFEL, CW
    MURPHY, ML
    SHIN, SH
    EXPERIENTIA, 1993, 49 (10): : 836 - 839